This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing
Scientific Reports Open Access 07 August 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pattanayak, V., Ramirez, C.L., Joung, J.K. & Liu, D.R. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat. Meth. 8, 765–770 (2011).
Gabriel, R. et al. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat. Biotechnol. 29, 816–823 (2011).
Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851–857 (2009).
Zou, J. et al. Oxidase deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease mediated safe harbor targeting. Blood 117, 5561–5572 (2011).
ENCODE Project Consortium et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799–816 (2007).
Li, H. et al. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475, 217–221 (2011).
Porteus, M.H. & Baltimore, D. Chimeric nucleases stimulate gene targeting in human cells. Science 300, 763 (2003).
Pruett-Miller, S.M., Reading, D.W., Porter, S.N. & Porteus, M.H. Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels. PLoS Genet. 5, e1000376 (2009).
Ethics declarations
Competing interests
K.H. is a co-inventor on a pending patent using zinc finger nucleases to do genome editing in hemophilia.
Rights and permissions
About this article
Cite this article
Zinc fingers hit off target. Nat Med 17, 1192–1193 (2011). https://doi.org/10.1038/nm1011-1192
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1011-1192
This article is cited by
-
Slivers of the spectrum
Nature Biotechnology (2021)
-
Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases
Molecular Therapy (2016)
-
Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing
Scientific Reports (2013)
-
TALEN-based Gene Correction for Epidermolysis Bullosa
Molecular Therapy (2013)